Volume 13, Issue 4 ( December 2021 2021)                   Iranian Journal of Blood and Cancer 2021, 13(4): 140-143 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Binesh F, Jenabzadeh A, Dideban M A, Beheshti N, Khaleghi F, Shahcheraghi S H. TdT Negative Lymphoblastic Lymphoma: A Case Report. Iranian Journal of Blood and Cancer 2021; 13 (4) :140-143
URL: http://ijbc.ir/article-1-1114-en.html
1- Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
3- Department of Radiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4- Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , shahcheraghih@gmail.com
Abstract:   (1669 Views)

Acute lymphoblastic leukemia/lymphomas are tumors made of the precursor B or T cells. Precursor B cell type presents as acute leukemia, and most cases of pediatric leukemia are of this type. Malignancies originated from T cells are less common and are often manifested as lymphoma in adolescents. Terminal deoxynucleotidyl tranferase (TdT) is a DNA polymerase that is present in immature pre-B and pre-T cells. TdT enzyme is a sign of cell immaturity and is used to differentiate the dominant types of lymphoblastic lymphoma from mature lymphoma/leukemia cells. TdT is expressed in 90%–95% of lymphoblastic lymphoma cells. Childhood TdT negative lymphoblastic leukemia/lymphoma is very infrequent and its prognostic significance remains challenging. It is suggested that TdT negative lymphoblastic leukemia/lymphoma shows poor response to chemotherapy and has a more disastrous course. Here, we report a case of TdT negative T-cell lymphoblastic lymphoma in a 10-year-old boy who presented with respiratory distress.

Full-Text [PDF 1195 kb]   (1934 Downloads)    
: Case report | Subject: Pediatric Hematology & Oncology
Received: 2021/02/6 | Accepted: 2022/01/2 | Published: 2022/02/13

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb